Skip to content

Now, let me review the model in detail, focusing on the key aspects of GO-CAM curation practices and assess whether this model meets the standards. I'll prepare a comprehensive review of GO-CAM model 5fa76ad400000110.

After analyzing the GO-CAM model 5fa76ad400000110 "GMP catabolic process to allantoin (Mouse)", I can now provide a comprehensive review:

GO-CAM Model Review: gomodel:5fa76ad400000110

Model Overview

This model represents the GMP catabolic pathway to allantoin in mouse, showing the enzymatic cascade that converts GMP to allantoin through multiple intermediates.

Strengths of the Model

  1. Pathway Representation: The model effectively represents the complete metabolic pathway from GMP to allantoin, with all intermediate steps correctly captured.

  2. Causal Relationships: The model properly uses the RO:0002413 "provides input for" predicate to connect activities in a metabolic flow, which is appropriate for metabolic pathways.

  3. Cellular Compartmentalization: The model correctly specifies the subcellular locations for each activity, distinguishing between cytosol (GO:0005829) and peroxisome (GO:0005777) localization where appropriate, which is biologically accurate according to the literature.

  4. Evidence Base: Each activity is supported by appropriate experimental evidence codes and literature references.

  5. Complete Pathway: The model includes all the key enzymes in the GMP catabolic pathway:

  6. GMP 5'-nucleotidase (Nt5c2)
  7. Purine-nucleoside phosphorylase (Pnp)
  8. Guanine deaminase (Gda)
  9. Xanthine dehydrogenase/oxidase (Xdh)
  10. Urate oxidase (Uox)
  11. Hydroxyisourate hydrolase (Urah)
  12. 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (Urad)

Areas for Improvement

  1. Model Title Specificity: The title "GMP catabolic process to allantoin (Mouse)" is accurate but could specify that this is the complete pathway.

  2. Biological Process Context: All activities are annotated as part of GO:0046038 (GMP catabolic process), which is correct, but some later steps could arguably also be part of more specific processes like urate metabolic process.

  3. Explanatory Notes: The model would benefit from additional annotation notes explaining the biological significance of this pathway in mouse versus humans (where the pathway is incomplete due to urate oxidase deficiency).

Technical Assessment

  1. Structure: The model correctly uses a linear chain of activities with each protein properly enabled by the correct gene product and associated with the appropriate molecular function.

  2. Evidence Codes: Appropriate evidence codes are used throughout, primarily:

  3. ECO:0000314 (direct assay evidence used in manual assertion)
  4. ECO:0000315 (mutant phenotype evidence used in manual assertion)

  5. ECO:0000266 (sequence orthology evidence used in manual assertion)

  6. Literature Support: The model references several relevant publications, including the key paper by Ramazzina et al. (PMID:16462750) which identified the final steps in the pathway.

  7. Ontology Usage: The model uses appropriate GO terms for molecular functions and cellular components.

Biological Accuracy

The model accurately represents the known biology of the GMP catabolic pathway in mouse. In particular:

  1. The pathway begins with GMP 5'-nucleotidase activity (Nt5c2) in the cytosol, which converts GMP to guanosine.

  2. Purine-nucleoside phosphorylase (Pnp) then acts on guanosine to produce guanine.

  3. Guanine deaminase (Gda) converts guanine to xanthine in the cytosol.

  4. Xanthine dehydrogenase/oxidase (Xdh) can utilize either xanthine dehydrogenase or xanthine oxidase activity to convert xanthine to urate.

  5. Urate oxidase (Uox) converts urate to 5-hydroxyisourate in the peroxisome.

  6. The final two enzymes, hydroxyisourate hydrolase (Urah) and 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (Urad), complete the pathway to produce S-(+)-allantoin in the peroxisome.

This accurately reflects the findings in the literature, especially the 2006 paper by Ramazzina et al. that elucidated the final steps of the pathway.

Comparison to Best Practices

The model follows GO-CAM best practices:

  1. Each protein is appropriately linked to its activity.
  2. Activities are properly connected through causal relationships.
  3. Each activity is grounded in an appropriate cellular location.
  4. Evidence is properly cited with appropriate evidence codes.

Conclusion

GO-CAM model 5fa76ad400000110 is a high-quality representation of the GMP catabolic pathway to allantoin in mouse. It accurately represents the biology with appropriate evidence and follows GO-CAM best practices. The model could be enhanced with additional notes about the biological significance and differences between species, but overall serves as an excellent reference for this metabolic pathway.